PVIVAX

Knowledge sharing for relapsing malaria

PVIVAX Knowledge sharing for relapsing malaria

Search

  • P. vivax malaria
    • Malaria and P. vivax malaria
    • Symptoms & severity
    • Illness and mortality
    • Populations at risk
      • Pregnant women and children
      • Migratory populations
    • Role in malaria elimination
    • Lifecycle
    • Relapses
    • Vectors
  • Diagnosis & treatment
    • Diagnostic methods
      • Microscopy
      • Rapid diagnostic tests
      • Molecular methods & serology
    • Diagnosing severe vivax malaria
    • Treatment
      • Radical cure
      • Blood stage treatment
      • Liver stage treatment
    • G6PD Deficiency
      • G6PD Global Prevalence
      • G6PD diagnostics
      • Types of G6PD clinical diagnostic tests
  • Regions & countries
    • Africa
    • Eastern Mediterranean
    • South East Asia
    • The Americas
    • Western Pacific
  • In the field
    • Projects
      • The Partnership for Vivax Elimination (PAVE)
    • Stories and Videos
  • Tools
    • Study database
  • Resources
  • News & events
    • Past events
  • About us
HomeRegions & countriesSouth East Asia

South East Asia

Two of out the five highest burden P. vivax countries (India and Indonesia) are in South East Asia. About 56% of estimated vivax malaria cases in 2017 occurred in these two countries.1

 

Source: World Malaria Report 2022

Source: World Malaria Report 2022

Source: World Malaria Report 2022

Source: World Malaria Report 2022

Disclaimer

Disclaimer: MMV accepts no liability for the information presented here or for the consequences of any actions taken on the basis of this information. 

0

Featured countries with P. vivax malaria

Photo: Hadynyah/istock

India

India bears the largest burden of P. vivax malaria cases globally with over 3.6 million cases (48% of global P. vivax malaria cases) occurring in India. 
Photo: Marco Corsi/Sigma-Tau

Myanmar

Photo: Elizabeth Poll/MMV

Thailand

Photo: Anna Wang/MMV

Nepal

About 8.2 million people are at risk of malaria in Nepal. Despite this progress, there was a 13.5% increase from 2017 to 2018.
0

Related resources

15 Jul 2017

Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymatic disorder in humans and appears to be protective against falciparum severe malaria. Controversially, it is also thought that Plasmodium vivax has driven the recent selection of G6PD alleles.

J Infect Dis
Peer-reviewed article
19 Jul 2017

A dual colour fluorescence in situ hybridization (FISH) assay for identifying the zoonotic malaria parasite Plasmodium knowlesi with a potential application for the specific diagnosis of knowlesi malaria in peripheral-level laboratories of Southeast Asia.

The use of a simple and inexpensive dual-colour fluorescence in situ hybridization (FISH) assay, analogous to FISH assays recently described for Plasmodium falciparum and Plasmodium vivax, was investigated as a potential tool for identifying P. knowlesi.

Parasit Vectors
Peer-reviewed article

References

1 World Malaria Report 2022

Get in touch

Contact us.

Submit information

Subscribe

Join the mailing list

Follow us

  • Twitter
  • LinkedIn
  • Facebook
  • Disclaimer
  • Privacy policy
A Remora website by Manta Ray Media